Comparison between kit eflornithine
(DFMO) and kit NECT (estimation)

(Source WHO/MSF-Logistique)
Cost of treatment cut in half, available at 222.5 €

  • With less eflornithine, less intravenous infusion equipment and infusion fluids used, the cost of a NECT treatment has been reduced by 50 %.

   Cost of transport less than half due to reduced weight 
 and volume

  • The cost of transportation per patient goes down by half, since one kit can contain 4 full treatments instead of the 2 full treatments for eflornithine monotherapy. Sending 1 treatment of eflornithine from the MSF Logistique warehouse in France to Kinshasa in DRC costs 21.7 Euros. The cost of transport for 1 treatment of NECT is only 9.4 Euros.

         Cost of hospitalisation significantly reduced

  • With NECT, drugs have to be administered only during 12 hour a day instead of 24 hours. The patients receive their 2 injections during day time. This reduces the cost for medical staff dramatically.
  • A patient treated with NECT needs to stay in hospital for 10 days instead of 14 when treated with eflornithine monotherapy. This also necessitates less staff time to administer and monitor the treatment.